Q1 2024 Holdings
Filed 2024-05-15 | 74 holdings | $1.8B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-08-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Align Technology Inc(ALGN) | COM | 016255101 | $31.3M | 95,478 | 1.7% |
| Inozyme Pharma Inc | COM | 45790W108 | $32.8M | 4,280,308 | 1.8% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $33.7M | 801,777 | 1.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $34.3M | 781,596 | 1.9% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $35.7M | 2,194,278 | 2.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $37.7M | 220,203 | 2.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $38.3M | 1,608,540 | 2.1% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $40.4M | 596,713 | 2.3% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $40.6M | 75,224 | 2.3% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $41.6M | 2,555,547 | 2.3% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $45.5M | 1,302,645 | 2.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $55.0M | 1,936,650 | 3.1% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $56.2M | 140,880 | 3.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $58.8M | 149,300 | 3.3% |
| Incyte Corp(INCY) | COM | 45337C102 | $75.6M | 1,327,178 | 4.2% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $78.6M | 611,884 | 4.4% |
| Spdr Ser Tr(XBI)Put | S&P BIOTECH | 78464A870 | $80.7M | 850,000 | 4.5% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $85.9M | 651,299 | 4.8% |
| Aerovate Therapeutics Inc | COM | 008064107 | $111.1M | 3,758,686 | 6.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $114.0M | 754,032 | 6.3% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $120.5M | 2,793,987 | 6.7% |
| Natera Inc(NTRA) | COM | 632307104 | $141.8M | 1,550,280 | 7.9% |